Africa Healthcare Market Outlook: Opportunity and Demand Analysis, Market Forecast, 2016-2024

Healthcare Market in Africa

Market Outlook

Africa is mostly an agrarian economy; they are unable to grow economically because of fossilized pre-industrial and pre-agrarian-revolution social formations. With no industrial revolution, socio-economic structures are in degenerative state rather than accumulative state. With the evolving disease pattern, diseases such as malaria, tuberculosis and HIV/AIDS are globally present though but others like sleeping sickness are specific to Africa. Inoculation, vaccination and other preventions are available but lack of easy access to health clinics and high cost of certain treatments put help out of reach for the maximum population. Malaria is widespread and kills one African child every 30 seconds, leading cause of death among under-fives in many countries. Bilharzia (also known as Schistosomiasis) is another common disease, caused by parasites which live and breed in some freshwater snails. Lassa fever, specific to West Africa, is highly contagious and can cause severe illness. However, polio is eradicated from many parts of the world, is still endemic in Nigeria and outbreaks occur in other parts of Africa. Other common diseases include elephantiasis, leprosy, helminthiasis and trachoma. If ignored, most diseases will cause severe debilitation which limits the sufferer’s ability to earn a living.

Out of 1 billion inhabitants, 90% will be under 60 age group which tends to transform the healthcare industry in Africa.

In 2016, Flint Atlantic (Nigerian based healthcare impact investment firm) announced an investment jointly with US-based Polaris Partners (Polaris), a leading global healthcare venture capital firm to fund AHN’s expansion in Rwanda and across Africa over the next two years. Private providers sense opportunity in Africa healthcare, for instance, in Nigeria, where it has sold portable ultrasound scanners, GE has trained carers in remote villages how to identify the biggest pregnancy-complication risks.

Market Segmentation

By Type

• Pharmaceuticals
• Services
• Devices (medical equipments)
•  Others (reagents and disposables)

By Sector

• Public
• Private

By Application

• Cardiovascular
• Oncology
• Anti-infection
• CNS
• Respiratory
• Others (dermatology, dentistry, diabetes, etc)

By End User

• Hospitals/clinics
• Diagnostic Labs
• Homecare Settings
• Research and Development Centers

By Region

• West Africa (Benin, Cape Verde, Ghana, Guinea, Mali, Nigeria) {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
• East Africa (Burundi, Dijbouti, Ethiopia, Kenya, Madagascar, Rwanda, Tanzania, Uganda, Zambia) {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
• North Africa (Algeria, Egypt, Libya, Morocco, Tunisia, Sudan) {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
• South Africa (Botwana, Lesotho, Namibia, South Africa and Swaziland) {Market Share (%), Market Size (USD Million), Adoption Rate (%)}
• Central Africa (Central African Republic, Chad, Congo Republic, Angola, Cameroon) {Market Share (%), Market Size (USD Million), Adoption Rate (%)}

Market Size & Forecast to 2024

According to the International Finance Corporation and World Bank, African healthcare sector valued USD 35 billion in 2016 and tends to increase by the projected CAGR of 6% over the forecast years.  

African pharmaceutical market was USD 19 billion in 2016 and is expected to reach USD 62 billion by 2024. Emerging private healthcare is contributing to the growth of African health system.

Countries like Botswana, South Africa, Mauritius and Lesotho that had the most room for improvement among others owing to relatively high life expectancy and expenditure on healthcare. Botswana has brunt of the AIDS epidemic with remarkable resilience and is now one of the highest life expectancies in Africa.

Market Dynamics-Growth Drivers & Challenges

Transforming healthcare system such as hospitals/clinics integrating IT with operations, in-country manufacturing, increasing options for micro-insurance, improvisation of care delivery, more solutions for providing POC healthcare, increasing focus on home diagnostics are driving the African Healthcare Market. Socio-political movements associated with decreasing Africa’s dependence on foreign aid is gaining traction and efforts of regulatory harmonization across Africa tend to brighten up the African healthcare industry.

Challenging factors based on health workforce, medical products, vaccines and technologies, information, financing, and services delivery hinders the African healthcare system. Additionally, continuous confrontation by communicable and non-communicable diseases weakens the health system across Africa.

Market Opportunities

• Addis, in Ethiopia, is a market not to be missed for growing opportunities in the healthcare sector owing to its growing private sector
• Beyond being a supplier other trends like training, services and low cost manufacturers have the scope to establish themselves in the Africa healthcare industry
• There are ample of funds available to solve African healthcare issues leading to the growth of number of digital startups like Ampion

Current Scenario of African Pharmaceutical Market

• Nigeria has four MRI machines for almost 200 million inhabitants
• The Mansour Group, an Egyptian conglomerate generating USD 6 billion annually is actively considering moving into healthcare which operates in 14 sub-Saharan countries selling products from excavators to hamburgers
• Babylon, a UK based start up raised USD 60 million to build an AI doctor, started offering telephonic digital consultation to people of Rwanda.
• There is the possibility that public health sectors can’t cope and therefore there is huge investment opportunity for private investors. For instance, Leapfrog  an insurance-focused private equity firm has taken USD 22 million stake in Goodlife Pharmacies, a Kenya based chain which perform simple site tests. It has expanded its branches from 19 to 30 and plans to attain 40 branches across the country
• Indian pharma company Cipla has signed a agreement for first biosimilars  manufacturing facility in South Africa cost nearly USD 91 million
• FMCG subsidiary Marico has acquired Ingwe, over-the-counter healthcare brand 
• Around 45% Nigerian visits India for healthcare services and contribute to the approx market of USD 0.75 billion

Key Market Players

• Siemens
• LIFE Healthcare Group
• Mediclinic International
• Netcare
• Litha Healthcare Group
• Medtronics
• Roche
• Alere
• GE Healthcare
• B Braun
• Abbott

Covered in this Report

Market Synopsis

Market Segmentation

The Africa Healthcare Market is segmented as follows:

• By Type (Market Size, Demand Analysis and Growth Analysis)
• By Sector (Market Size, Demand Analysis and Growth Analysis)
• By Application (Market Size, Demand Analysis and Growth Analysis)
• By End-User (Market Size, Demand Analysis and Growth Analysis)

By Regions

• West Africa (Benin, Cape Verde, Ghana, Guinea, Mali, Nigeria) {Market Size, Growth Analysis and Opportunity Analysis}
• East Africa (Burundi, Dijbouti, Ethiopia, Kenya, Madagascar, Rwanda, Tanzania, Uganda, Zambia) {Market Size, Growth Analysis and Opportunity Analysis}
• North Africa (Algeria, Egypt, Libya, Morocco, Tunisia, Sudan) {Market Size, Growth Analysis and Opportunity Analysis}
• South Africa (Botwana, Lesotho, Namibia, South Africa and Swaziland) {Market Size, Growth Analysis and Opportunity Analysis}
• Central Africa (Central African Republic, Chad, Congo Republic, Angola, Cameroon) {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

• Risk Factors
• Regional Variations
• Recent Trends and Developments

Key Market Players

• Synopsis
• Business Strategy
• Product Portfolio
• SWOT Analysis

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks